---
title: "Ketorolac Tromethamine - Allergic Conjunctivitis"
sidebar: mydoc_sidebar
permalink: dbsalt001045-mesh-d003233-1.html
toc: false 
---


Path ID: `DBSALT001045_MESH_D003233_1`
{% include image.html url="images/dbsalt001045-mesh-d003233-1.png" file="dbsalt001045-mesh-d003233-1.png" alt="dbsalt001045-mesh-d003233-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DBSALT001045 | Ketorolac tromethamine | Drug |
| UniProt:P35354 | Prostaglandin G/H synthase 2 | Protein |
| UniProt:P23219 | Prostaglandin G/H synthase 1 | Protein |
| MESH:D011453 | Prostaglandins | ChemicalSubstance |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D003233 | Allergic conjunctivitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ketorolac Tromethamine | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 2 |
| Ketorolac Tromethamine | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 1 |
| Prostaglandin G/H Synthase 2 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandin G/H Synthase 1 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandins | PARTICIPATES IN | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Allergic Conjunctivitis |
|---------|-----------|---------|

Comment: In the DrugCentral the drug trometamol (tromethamine) was indicated for allergic conjunctivitis, however no literature evidences found about the mechanism of action of trometamol treating allergic conjunctivitis. For the treatment of allergic conjunctivitis the ketorolac tromethamine is used.

Reference: 
  - [https://go.drugbank.com/salts/DBSALT001045](https://go.drugbank.com/salts/DBSALT001045)
  - [https://pubmed.ncbi.nlm.nih.gov/18433352/](https://pubmed.ncbi.nlm.nih.gov/18433352/)
